Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 2024-03-13 13:57 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Harald Gurvin | – | acquisition | 14 | 13,99 NOK | 2024-03-13 | NO0010714785 | XOSL - Oslo Stock Exchange | rules |
Vedlegg
- Attachment 240313.pdf (tekst hentet ut)
Meldingstekst
Oslo, Norway, March 13, 2024 - Primary insider Harald Gurvin, Chief Financial Officer of Nykode Therapeutics ASA, has today acquired 10,000 shares in Nykode Therapeutics ASA at an average price of NOK 14.00 per share. Following the transaction, Harald Gurvin holds 30,000 shares in Nykode Therapeutics ASA.
Please see further details in the attached document.